Compare GRFS & PACS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GRFS | PACS |
|---|---|---|
| Founded | 1940 | 2013 |
| Country | Spain | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.2B | 6.5B |
| IPO Year | 2006 | 2024 |
| Metric | GRFS | PACS |
|---|---|---|
| Price | $8.87 | $38.87 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | $10.15 | ★ $39.67 |
| AVG Volume (30 Days) | 485.7K | ★ 1.2M |
| Earning Date | 07-28-2022 | 03-13-2026 |
| Dividend Yield | ★ 1.60% | N/A |
| EPS Growth | N/A | ★ 176.35 |
| EPS | 0.64 | ★ 1.04 |
| Revenue | ★ $8,821,017,248.00 | $5,138,841,000.00 |
| Revenue This Year | $5.36 | $32.53 |
| Revenue Next Year | $5.15 | $7.71 |
| P/E Ratio | ★ $17.46 | $37.28 |
| Revenue Growth | 7.31 | ★ 37.58 |
| 52 Week Low | $6.19 | $7.50 |
| 52 Week High | $11.14 | $43.08 |
| Indicator | GRFS | PACS |
|---|---|---|
| Relative Strength Index (RSI) | 44.66 | 60.28 |
| Support Level | $8.79 | $38.10 |
| Resistance Level | $9.40 | $43.08 |
| Average True Range (ATR) | 0.24 | 1.86 |
| MACD | -0.05 | -0.69 |
| Stochastic Oscillator | 12.18 | 26.09 |
Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.
PACS Group Inc is a post-acute healthcare company mainly focused on delivering high-quality skilled nursing care through a portfolio of independently operated facilities Its is a nursing providers in the United States based on number of facilities, with over 200 post-acute care facilities across nine states serving over 20,000 patients daily. It also provide senior care, assisted living, and independent living options in some of communities.